Ravi Misra
Stock Analyst at Truist Financial
(0.59)
# 4,375
Out of 5,090 analysts
52
Total ratings
36.4%
Success rate
-8.8%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Reiterated: Buy | $53 → $60 | $49.37 | +21.53% | 3 | Oct 29, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Hold | $22 → $28 | $30.87 | -9.30% | 4 | Oct 28, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Hold | $15 → $13 | $12.75 | +1.96% | 7 | Oct 26, 2026 | |
| ORGO Organogenesis Holdings | Reiterated: Hold | $2 | $0.7681 | +160.38% | 3 | Aug 11, 2026 | |
| TFX Teleflex | Reiterated: Hold | $143 → $150 | $139.77 | +7.32% | 3 | Aug 10, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $149.89 | n/a | 4 | Dec 13, 2021 | |
| AMWL American Well | Rated: Hold | n/a | $12.73 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $82.29 | n/a | 2 | Dec 13, 2021 | |
| GKOS Glaukos | Rated: Hold | n/a | $237.60 | n/a | 2 | Dec 13, 2021 | |
| INSP Inspire Medical Systems | Rated: Hold | n/a | $68.10 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3301 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $149.68 | n/a | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.51 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.11 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $432.01 | n/a | 1 | Apr 19, 2017 |
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $49.37
Upside: +21.53%
OrthoPediatrics
Oct 28, 2026
Reiterated: Hold
Price Target: $22 → $28
Current: $30.87
Upside: -9.30%
Integra LifeSciences Holdings
Oct 26, 2026
Reiterated: Hold
Price Target: $15 → $13
Current: $12.75
Upside: +1.96%
Organogenesis Holdings
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $0.7681
Upside: +160.38%
Teleflex
Aug 10, 2026
Reiterated: Hold
Price Target: $143 → $150
Current: $139.77
Upside: +7.32%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $149.89
Upside: n/a
American Well
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $12.73
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $82.29
Upside: n/a
Glaukos
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $237.60
Upside: n/a
Inspire Medical Systems
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $68.10
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $0.3301
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $149.68
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $8.51
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $19.11
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $432.01
Upside: n/a